Bruker Corporation

Symbol: BRKR     Sector: Healthcare     Industry: Medical Diagnostics & Research

Dividend Yield
0.32%
Current Price
$49.25
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2018

Update: 2019-06-10 20:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
551,700,000
553,600,000
280,800,000
272,800,000
166,100,000
106,700,000
78,100,000
1,304,300,000
2,128,600,000
1,223,500,000
896,600,000
326,300,000
18,500,000
322,400,000
341,100,000
52,600,000
132,300,000
 
44,800,000

Q 3

2018-09-30
465,100,000
466,600,000
244,000,000
222,600,000
151,200,000
71,400,000
43,400,000
1,261,500,000
1,889,100,000
1,063,900,000
816,900,000
274,800,000
15,400,000
270,100,000
240,600,000
13,000,000
27,500,000
 
41,800,000

Q 2

2018-06-30
441,600,000
443,700,000
238,500,000
205,200,000
157,000,000
48,200,000
31,200,000
1,182,000,000
1,806,000,000
1,020,700,000
776,600,000
262,500,000
15,000,000
258,700,000
220,600,000
-14,800,000
36,100,000
 
43,600,000

Q 1

2018-03-31
429,900,000
431,700,000
232,300,000
199,400,000
157,000,000
42,400,000
27,000,000
1,240,500,000
1,830,500,000
1,040,200,000
781,500,000
287,800,000
15,000,000
283,900,000
220,600,000
-46,900,000
43,800,000
 
43,200,000

Financials 2017

Update: 2019-06-10 20:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
528,100,000
530,500,000
277,300,000
253,200,000
158,100,000
95,100,000
-3,400,000
1,358,800,000
1,948,500,000
1,215,000,000
725,400,000
328,900,000
-
439,200,000
-
58,700,000
103,700,000
 
44,200,000